Home / Products / Biosynthesis Chemicals / Enzyme Inhibitors / TACE Inhibitors /

TACE Inhibitors

TACE inhibitors also known as TNF-alpha converting enzyme inhibitors are a class of pharmaceutical compounds designed to suppress the activity of the TNF-alpha converting enzyme This enzyme plays a crucial role in the processing of tumor necrosis factor-alpha (TNF-alpha) a potent pro-inflammatory cytokine By inhibiting TACE these inhibitors can effectively reduce the release of TNF-alpha thus providing therapeutic benefits in various inflammatory conditions such as rheumatoid arthritis and psoriasis Our company offers a range of high-quality TACE inhibitors that have been extensively researched and proven to be effective in suppressing TNF-alpha activity

Get A Quote
Products Application Supporting Data Resources Related Products

Products

Catalog Number Chemical Name CAS # Price
EI-2114 TAPI-0 143457-40-3 Online Inquiry
EI-2116 TAPI-2 187034-31-7 Online Inquiry

Application

TACE inhibitors have a wide range of applications in the field of medicine particularly in the treatment of inflammatory diseases and certain forms of cancer These inhibitors target a specific enzyme called TACE (TNF-alpha converting enzyme) that is involved in the production of pro-inflammatory cytokines By blocking the activity of TACE these inhibitors can help reduce inflammation and alleviate symptoms associated with conditions such as rheumatoid arthritis psoriasis and inflammatory bowel disease

Furthermore TACE inhibitors also show promise in the treatment of certain types of cancer TACE plays a role in the release of growth factors and cell signaling molecules that promote tumor growth and metastasis By inhibiting TACE these inhibitors can potentially slow down the progression of cancer and suppress tumor growth

The development and use of TACE inhibitors represent a significant advancement in the field of targeted therapies offering a potential alternative or complementary approach to traditional treatments As further research and clinical trials continue the applications of TACE inhibitors may expand providing new options for patients suffering from inflammatory diseases and cancer

Supporting Data

Resources

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.